6 completed, 2 suspended, 1 unknown. 6 Phase 2, 4 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Suspended 2, Unknown 1 |
| Phase 1 | 4 | Completed 3, Suspended 1 |
| Not applicable | 1 | Completed 1 |
Follow Oshadi Drug Administration: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients Oshadi D & Oshadi R;, salvage therapy cytosar and mitoxantrone - Acute Myeloid Leukemia, Lymphoid Leukemia | Phase 2 | Suspended | Oshadi Drug Administration | 15 | 2017-01-01 | 2018-04-18 |
| Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment Oshadi D and Oshadi R - Mesothelioma | Phase 1 / Phase 2 | Suspended | Oshadi Drug Administration | 17 | 2016-12-01 | 2018-04-18 |
| Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer Oshadi D and Oshadi R, Docetaxel - Carcinoma, Non-Small-Cell Lung | Phase 2 | Unknown | Oshadi Drug Administration | 20 | 2014-06-01 | 2018-04-18 |
| Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical Study Oshadi Icp - Diabetes Mellitus, Insulin-Dependent | Phase 2 | Completed | Oshadi Drug Administration | 12 | 2013-12-01 | 2018-04-18 |
| Safety and Efficacy of Oshadi D and Oshadi R in Basal Cell Carcinoma Patients Prior to Tumor Excision a Phase 2 Study Oshadi D & Oshadi R - BCC | Phase 2 | Completed | Oshadi Drug Administration | 30 | 2013-11-01 | 2018-04-18 |
| Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study Oshadi Icp - Diabetes Mellitus, Insulin-Dependent, 1 | Phase 1 / Phase 2 | Completed | Oshadi Drug Administration | 10 | 2013-02-01 | 2013-10-29 |
| Evaluation of the Influence of Food Regimen on Oshadi D Absorption Oshadi D - Lupus Erythematosus, Systemic | Not applicable | Completed | Oshadi Drug Administration | 8 | 2011-04-01 | 2012-06-21 |
| Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment Oshadi D, Oshadi R - Tumor, Cancer | Phase 1 | Completed | Oshadi Drug Administration | 7 | 2011-01-01 | 2012-06-21 |
| Safety and Efficacy of Single Administration of Oshadi Oral Insulin in Type I Diabetes Patients Oshadi Oral Insulin - Diabetes | Phase 1 | Completed | Oshadi Drug Administration | 8 | 2010-10-01 | 2012-04-17 |
Diabetes Mellitus (3) · Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Diabetes Mellitus, Type 1 (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid, Acute (1) · Lupus Erythematosus, Systemic (1) · Mesothelioma (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1)
Insulin (2) · Antineoplastic Agents (1) · Docetaxel (1) · Mitoxantrone (1)
Israel (8)
Hanna Levy, Dr. (2) · Hovav Nehushtan, Prof. (2) · Avishai Sella, Prof. (1) · Keren Duanis, MD (1) · Lior Heller, Prof. (1) · Marianna Rachmiel, Dr. (1) · Moshe Gatt, MD (1)